Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Healthcare Utilization and Costs in Patients With Asthma Who Fluticasone/Salmeterol Inhalation Powder Versus Other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.

NCT01332344 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01332344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01332344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Healthcare Utilization and Costs in Patients With Asthma Who Fluticasone/Salmeterol Inhalation Powder Versus Other Inhaled Corticosteroid(s) in Typical Clinical Practice Using Health Insurance Claims Data.
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
June 30, 2010
Enrollment
5,180 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma